Cooley advised HBM Healthcare Investments and certain other investors on their lead investment in Harmony Biosciences’ completed $270 million equity financing. Harmony used the proceeds of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
